Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given Average Rating of “Buy” by Brokerages

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a consensus recommendation of “Buy” by the fifteen analysts that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is €78.38 ($91.14).

Several analysts recently weighed in on FME shares. Nord/LB set a €82.00 ($95.35) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Wednesday, October 30th. Credit Suisse Group set a €71.00 ($82.56) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a report on Friday, October 18th. UBS Group set a €90.00 ($104.65) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Tuesday, October 29th. Sanford C. Bernstein set a €73.00 ($84.88) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Tuesday, November 12th. Finally, Independent Research set a €70.00 ($81.40) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Wednesday, October 30th.

Fresenius Medical Care AG & Co. KGaA stock traded up €0.94 ($1.09) during trading on Tuesday, hitting €67.24 ($78.19). The company had a trading volume of 1,001,165 shares, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €57.24 ($66.56) and a 1-year high of €76.68 ($89.16). The company has a current ratio of 0.98, a quick ratio of 0.62 and a debt-to-equity ratio of 101.27. The company’s 50 day simple moving average is €65.75 and its 200-day simple moving average is €64.35. The stock has a market cap of $20.20 billion and a price-to-earnings ratio of 16.00.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Further Reading: How to build a Fibonacci channel

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.